MedTrace Logo

Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI

NCT03709186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-04-11

No results posted yet for this study

Summary

The primary aim of the study is to identify radiomic features as biomarkers of metastatic progression following primary therapy.

Conditions

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • William T. Tran, MRT(T), PhD · Radiation Therapist Clinician Scientist

  • Colleen Bailey, PhD · Sunnybrook Research Institute

  • Angus Lau, PhD · Sunnybrook Research Institute

  • Kasia Jerzak, MD, MSc · Sunnybrook Health Sciences Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-09-01
Completion
2021-01-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03709186 on ClinicalTrials.gov